Clicky

Quest Diagnostics Inc.(0KSX)

Description: Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.


Keywords:

Home Page: www.questdiagnostics.com

0KSX Technical Analysis

500 Plaza Drive
Secaucus, NJ 07094
United States
Phone: 973 520 2700


Officers

Name Title
Mr. James E. Davis Chairman, CEO & President
Mr. Sam A. Samad Executive VP & CFO
Mr. Michael E. Prevoznik J.D. Senior VP & General Counsel
Ms. Catherine T. Doherty Executive Vice President of Regional Businesses
Mr. Karthik Kuppusamy Ph.D. Senior Vice President of Clinical Solutions
Mr. Michael J. Deppe Senior VP, Corporate Controller & Chief Accounting Officer
Mr. Murali Balakumar Senior VP, Chief Information & Digital Officer
Mr. Shawn C. Bevec Vice President of Investor Relations
Ms. Kristin Lee Wallace Esq. Senior VP & Chief Compliance Officer
Mr. Gary D. Samuels Senior VP & Chief Communications Officer

Exchange: LSE

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0.1044
Price-to-Book MRQ: 0
Price-to-Sales TTM: 2.2342
IPO Date:
Fiscal Year End: December
Full Time Employees: 50000
Back to stocks